Use this URL to cite or link to this record in EThOS:
Title: The pharmaceutical industry in Britain and France, 1919-1939.
Author: Robson, M.
ISNI:       0000 0004 2752 201X
Awarding Body: London School of Economics and Political Science (University of London)
Current Institution: London School of Economics and Political Science (University of London)
Date of Award: 1993
Availability of Full Text:
Access from EThOS:
This thesis describes the development of the pharmaceutical industry in Britain and France, focusing on the experience of individual firms during the inter war period. The resulting synthesis uses material from economic, technological, medical, social and business history traditions to create a picture of the forces affecting the performance of businesses in the two countries. It draws, in particular, on archival records from three companies - Burroughs Welicome, RhOne-Poulenc and Sandoz - which operated in Britain or France (or both), and which had made a commitment to research-based products. This is supported by other archival material and a review of published archivally-based studies on pharmaceutical companies (and other secondary sources) as well as contemporary trade and professional journals, and institutional archives including the Medical Research Council in Britain, and the Institut Pasteur and the Laboratoire National de Contrôle du Médicament in France. The structure holds both thematic chapters (on sizes and types of company, the medical context, and the institutional and regulatory context) and company-specific chapters. The key findings concern the widely different origins of the firms operating within the industry, the impact of the different legal framework governing the two markets, the changing nature of the marketing of pharmaceuticals during the period, and the adoption of diverse research and development strategies by companies in the two markets. The detailed case study research shows pharmaceutical companies playing an increasingly active role in trying to influence institutions, and the medical profession in both countries during the 1920s and 1930s. It also demonstrates the interplay between academic institutions and company research and development staff in work on new medicines. The main contribution of this thesis comes from the broad range of sources used and the way that new company sources are integrated with existing material to provide a comprehensive company-based account of the development of a sector of economic activity.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: Economics & economic theory